» Articles » PMID: 16012036

Comparative Study of Two Japanese Rhinoconjunctivitis Quality-of-life Questionnaires

Overview
Date 2005 Jul 14
PMID 16012036
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Conclusion: Two questionnaires were used to assess quality of life (QOL) in allergic rhinitis: the Japanese translation of the Rhino-conjunctivitis Quality of Life Questionnaire (RQLQJ) and an original Japanese QOL questionnaire (JRQLQ). Either questionnaire may be used to assess QOL depending on differences in target domains.

Objectives: Although pollinosis is a common disease which has a major impact on patient QOL, no internationally standardized questionnaire has been available in Japan until now. The aim of this study was to compare two currently available QOL questionnaires for allergic rhinitis in Japan-the RQLQJ and JRQLQ-in terms of their appropriateness for clinical use and their psychometric properties.

Material And Methods: A multicenter, inter-group, cross-sectional study was conducted in 187 adult symptomatic patients with Japanese cedar pollinosis in 2003. Patient scores on the two questionnaires were compared in terms of both overall and comparable domains. We also examined the acceptability, construct and reliability of both questionnaires.

Results: The questionnaires were highly correlated in terms of both overall and comparable domain scores. In addition, both questionnaires had equal and satisfactory psychometric validity, demonstrating that they are both useful tools for assessing QOL in rhinitis. However, when compared with each other, the JRQLQ focuses mainly on activities of daily life and is simpler, while the RQLQJ focuses mainly on rhinitis-related health and is more responsive.

Citing Articles

Development and validation of a health practitioner survey on ocular allergy.

Mikhail E, Mohebbi M, Gokhale M, Azizoglu S, Suphioglu C Sci Rep. 2024; 14(1):9932.

PMID: 38689009 PMC: 11061311. DOI: 10.1038/s41598-024-60837-6.


Supplementation of Dihomo-γ-Linolenic Acid for Pollen-Induced Allergic Symptoms in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Yokoi K, Yanagimoto K, Hayamizu K Nutrients. 2023; 15(15).

PMID: 37571402 PMC: 10421109. DOI: 10.3390/nu15153465.


Effectiveness and safety of allergen immunotherapy in patients with allergic rhinitis complicated by rheumatic autoimmune diseases: a case series study.

Fujioka K, Kasahara A, Kida T, Fujii W, Seno T, Wada M Allergy Asthma Clin Immunol. 2022; 18(1):63.

PMID: 35818067 PMC: 9275025. DOI: 10.1186/s13223-022-00703-0.


[Preliminary study on life quality assessment of adult allergic rhinitis in immunotherapy, drug guidance and supervised treatment].

Liu Y, Xiu Q, Zhu D, Meng C Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020; 34(3):259-263.

PMID: 32791596 PMC: 10127854. DOI: 10.13201/j.issn.2096-7993.2020.03.018.


Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial.

Okubo K, Suzuki T, Tanaka A, Aoki H J Drug Assess. 2019; 8(1):104-114.

PMID: 31231589 PMC: 6567265. DOI: 10.1080/21556660.2019.1614005.